NEW YORK, May 03, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class action lawsuits can be filed on behalf of shareholders of Fulcrum Therapeutics, Inc. FULCand adidas AG ADDY. Shareholders have until the deadlines below to petition the court to appear as lead plaintiffs. For more information on each case, see the link provided.

Fulcrum Therapeutics, Inc. FULC

Class period: March 3, 2022 – March 8, 2023

Lead Plaintiff Deadline: June 27, 2023

Throughout the class period, the defendants made materially false and misleading statements regarding the Company’s business, operations and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the pre-clinical data presented in support of FTX-6058 revealed safety concerns related to potential hematological malignancies; (ii) the foregoing safety concerns increased the likelihood that the FDA would suspend clinical trials of FTX-6058; (iii) accordingly, the Company had overstated the clinical and/or commercial prospects of FTX-6058; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

For more information on the Fulcrum class action go to: https://bespc.com/cases/FULC.

adidasAG ADDY

Class period: May 3, 2018 – February 21, 2023

Lead Plaintiff Deadline: June 27, 2023

During the Class Period, the Defendants made materially false and/or misleading statements by misrepresenting and failing to disclose the following adverse facts related to the Company’s business, operations and prospects that were known to the Defendants or recklessly ignored by them became. Specifically, the Defendants made false and/or misleading statements and/or withheld the following: (1) In addition to other wrongdoing, Kanye West made anti-Semitic remarks in front of adidas employees and even suggested naming an album after Adolf Hitler; (2)…

[ad_2]

Source story